Overview

Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma)

Status:
Unknown status
Trial end date:
2020-09-15
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy and safety of Chidamide plus CHOP regimen for de novo PTCL patients.
Phase:
N/A
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University
Treatments:
Cyclophosphamide
Doxorubicin
Etoposide
Prednisolone
Prednisone
Vincristine